However, current therapies aiming to specifically attenuate RV remodeling and improve RV function in PAH [68] did not pay attention to the ECG analysis that might suggest Cx43 disorders, as in HTN [59]. This evidence concerns the gene GJA1 and pulmonary arterial hypertension.